Medium materiality6/10
Truist raises Encompass Health price target to $156
Why it may matterVerify against the original reporting
Bullish analyst view, though a price target is an opinion rather than a guarantee.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Truist raised its EHC price target to $156, about 19% above the cited $131.49 price; the title also characterizes the firm as remaining bullish.
- Raised target: $156
- Cited price: $131.49
Key facts
- 01
Target: $156
- 02
Posted price: $131.49
- 03
Analyst firm: Truist Financial
- 04
Analyst: David MacDonald
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.